Zakaria Grada, MD
Specialties:
Pathology - Anatomic & Clinical
More specialties
Accepting New Patients
Profile Navigation
OverviewSchedule an Appointment
Insurance Accepted
Credentials & Experience
Research
Overview
Areas of Expertise / Conditions Treated
Anatomic PathologyClinical Pathology
Cytology
Academic Appointments
Assistant Professor of Pathology and Cell Biology at CUMCHospital Affiliations
NewYork-Presbyterian / Columbia University Irving Medical CenterGender
MaleSchedule an Appointment
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.Connect Sign In
Insurance Accepted
Aetna
EPOMedicare Managed Care
NYP Employee Plan
NY Signature
POS
Cigna
EPOGreat West (National)
HMO
POS
PPO
Emblem/GHI
Medicare Managed CarePPO
Emblem/HIP
ConnectiCareEPO
Essential Plan
HMO
Medicaid Managed Care
Medicare Managed Care
POS
PPO
Select Care (Exchange)
Vytra
Empire Blue Cross/Blue Shield
HMOPPO
Local 1199
Local 1199MagnaCare (National)
MagnaCareMedicare
RailroadTraditional Medicare
Multiplan
MultiplanOxford Health Plans
FreedomLiberty
RiverSpring
Special NeedsUnitedHealthcare
Compass (Exchange)Empire Plan
HMO
Medicare Managed Care
POS
PPO
*Please contact the provider’s office directly to verify that your particular insurance is accepted.
Credentials & Experience
Honors & Awards
24th Annual Hospital Research Celebration, Rhode Island Hospital: 2nd place winner, October 2016.The American Society for Gene and Cell Therapy: Merit Award, May, 2011.
Master degree Scholarship: Clinical Scientist Training Program, Baylor College of Medicine, 2010
Research
Selected Publications
Evangelou Z, Zhang L, Tafe LJ, Azzouz L, Grada Z, Linos K. Primary cutaneous Ewing sarcoma with diffuse S100/SOX10 positivity and pseudoalveolar pattern: An extraordinarily rare case highlighting a potential pitfall with significant repercussions. Journal of Cutaneous Pathology. 2021 Feb;48(2):302-308.Jamal SME, Alamodi A, Wahl RU, Grada Z, Shareef MA, Hassan SY, Murad F, Hassan SL, Santourlidis S, Gomez CR, Haikel Y, Megahed M, Hassan M. Melanoma stem cell maintenance and chemo-resistance are mediated by CD133 signal to PI3K-dependent pathways. Oncogene 39, 5468–5478 (2020).
Godbersen-Palmer C, Coupet TA, Grada Z, Zhang SC, Sentman CL. Toxicity Induced by a Bispecific T Cell-Redirecting Protein Is Mediated by Both T Cells and Myeloid Cells in Immunocompetent Mice. Journal of Immunology. 2020 Jun 1;204(11):2973-2983.
Amin A, Murati-Amador B, Lombardo KA, Jackson CL, Grada Z, Palsgrove DN, Matoso A. Analysis of Intestinal Metaplasia Without Dysplasia in the Urinary Bladder Reveal Only Rare Mutations Associated With Colorectal Adenocarcinoma. Applied Immunohistochemistry & Molecular Morphology. 2020 Nov/Dec;28(10):786-790.
Salama A, Marcellino BK, Saad AG, Teruya-Feldstein J, Firpo-Betancourt A, Abulsayen HA, Grada Z, Hassan M, El Jamal SM. Correlation Analysis Between the Expression of MEF2B, and Germinal Center and Nongerminal Center Markers in Diffuse Large B-Cell Lymphoma. Applied Immunohistochemistry & Molecular Morphology. 2020 Aug;28(7):e63-e64.
Saad A, Grada Z, Bishop B , Abulsayen H, Hasan M, Firpo-Betancourt A, Teruya-Feldstein J, Fraig M, El Jamal SM “nCounter NanoString Assay Shows Variable Concordance with Immunohistochemistry-Based Algorithms in
El Jamal SM, El Dinali MH, Grada Z, Hassan SY, Ghanjati F, Gibson B, Chastain E, Saad AG, Bishop BJ, Santourlidis S, Megahed M, Basso K, Fraig M, Hassan M “MEF2B Is a Member of the BCL6 Gene Transcriptional Complex and Induces Its Expression in GC-DLBCL”. Laboratory Investigation Journal, 2019 Apr;99(4):539-550.
Grada Z, Paquette C, Eklund CM, Zhang C, Sung CJ, Steinhoff M, Quddus MR. Evaluating the Age Cutoff Criterion for Reporting Benign-Appearing Endometrial Cells in Routine Pap Tests: An 8-Year Retrospective Review. Acta Cytologica. 2017;61(3):194-198. Epub 2017 May 10. PMID: 28486237
Scrimgeour LA, Grada Z, Aswad BI, Ng T. Lessons Learned from an Untreated “Benign” Thoracic Tumor. The Annals of Thoracic Surgery. 2017 Feb. PMID: 28109372.
Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed N. Tandem CAR T cells targeting HER2 and IL13Rá2 mitigate tumor antigen escape. Journal of Clinical Investigation. 2016 Aug. PMID: 27427982
Yakirevich E, Magi-Galluzzi C, Grada Z, Lu S, Resnick MB, Mangray S. Cadherin 17 is a sensitive and specific marker for metanephric adenoma. American Journal of Surgical Pathology. 2015 Apr;39(4):479-86. PMID: 25768256
Grada Z, Hegde M, Byrd T, Shaffer DR, Ghazi A, Brawley VS, Corder A, Sch?nfeld K, Koch J, Dotti G, Heslop HE. TanCAR: a novel bispecific chimeric antigen receptor for cancer immunotherapy. Molecular Therapy-Nucleic Acids. 2013 Jul 9;2:e105. PMID: 23839099
Ghazi A, Ashoori A, Hanley PJ, Brawley VS, Shaffer DR, Kew Y, Powell SZ, Grossman R, Grada Z, Scheurer ME, Hegde M, Leen AM, Bollard CM, Rooney CM, Heslop HE, Gottschalk S, Ahmed N. Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy Glioblastoma. Journal of Immunology. 2012 Feb-Mar;35(2):159-68. PMID: 22306904